Physician profile
David Gee Man
NPI 1366450637
$347.21
in general payments reported to CMS, 2019-2025
8 companies · $89.12 in 2025
The $89.12 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.87 · 2020: $22.35 · 2021: $62.78 · 2024: $129 · 2025: $89.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $218.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $99.79 | 2024-2025 | Amplatzer Amulet |
| Insmed, INC. | $66.38 | 2019-2021 | |
| Melinta Therapeutics, LLC | $56.28 | 2024-2025 | Kimyrsa, Rezzayo, Orbactiv |
| Pulmonx Corporation | $43.58 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Astellas Pharma US INC | $22.35 | 2020 | |
| Boston Scientific Corporation | $21.87 | 2019 | |
| Glaxosmithkline, LLC. | $18.56 | 2024 | Nucala |
| Regeneron Healthcare Solutions, INC. | $18.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Man listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.